戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  activation of protein kinase A (PKA; eg, by beta-adrenergic stimulation).
2 al fibrosis and attenuated responsiveness to beta-adrenergic stimulation).
3 restore myocyte contractility in response to beta adrenergic stimulation.
4 itoring [Ca(2+)](SR) and Ca(2+) waves during beta-adrenergic stimulation.
5   Surprisingly, BAT was not activated during beta-adrenergic stimulation.
6  to achieve localized temporal regulation of beta-adrenergic stimulation.
7 wo steps of adipose lipolysis in response to beta-adrenergic stimulation.
8 ular arrhythmias in young individuals during beta-adrenergic stimulation.
9  phosphorylation and cardiac function during beta-adrenergic stimulation.
10 duced heart rate in response to work load or beta-adrenergic stimulation.
11 evelopment of cardiac hypertrophy induced by beta-adrenergic stimulation.
12 entials; the firing frequency increased with beta-adrenergic stimulation.
13 en species and induction of autophagy during beta-adrenergic stimulation.
14 output changes and is accompanied in vivo by beta-adrenergic stimulation.
15 he L-type Ca2+ channel Cav1.2 in response to beta-adrenergic stimulation.
16 the systolic Ca2+ transient alone and during beta-adrenergic stimulation.
17 ocardial contractility and relaxation during beta-adrenergic stimulation.
18 inetics observed in living myocardium during beta-adrenergic stimulation.
19 n by sildenafil blunts systolic responses to beta-adrenergic stimulation.
20 dels of I(Ks) in the absence and presence of beta-adrenergic stimulation.
21 ced calcium entry, using I(Ks) blockade with beta-adrenergic stimulation.
22 ilar to that of wild type mouse hearts under beta-adrenergic stimulation.
23 horylated by protein kinase A in response to beta-adrenergic stimulation.
24 ions that may be especially important during beta-adrenergic stimulation.
25 elaxation was significantly decreased during beta-adrenergic stimulation.
26 he hypertrophic and antiapoptotic effects of beta-adrenergic stimulation.
27 butes to increased rate of relaxation during beta-adrenergic stimulation.
28 phorylation in accelerating relaxation after beta-adrenergic stimulation.
29 ase channel (ryanodine receptor, RyR) during beta-adrenergic stimulation.
30 ting brown adipocyte function in response to beta-adrenergic stimulation.
31 nt but modifies the hypertrophic response to beta-adrenergic stimulation.
32 nction by phospholamban is a major target of beta-adrenergic stimulation.
33 ergy metabolism, and an abnormal response to beta-adrenergic stimulation.
34 ute to greater contractility in hearts after beta-adrenergic stimulation.
35 I and is essential to the relaxant effect of beta-adrenergic stimulation.
36 r mediating the maximal cardiac responses to beta-adrenergic stimulation.
37 ipates in NO-mediated negative feedback over beta-adrenergic stimulation.
38 , whereas beta-lumicolchicine did not affect beta-adrenergic stimulation.
39 ased by voluntary exercise and by persistent beta-adrenergic stimulation.
40 ulum through PLB phosphorylation mediated by beta-adrenergic stimulation.
41 (SR) through PLB phosphorylation mediated by beta-adrenergic stimulation.
42 inephrine, but not with selective alpha- and beta-adrenergic stimulation.
43 ted, it was no longer sensitive to volume or beta-adrenergic stimulation.
44 ystolic intracellular calcium in response to beta-adrenergic stimulation.
45 ine but preserved NO activity in response to beta-adrenergic stimulation.
46 markedly blunted the contractile response to beta-adrenergic stimulation.
47 lowed relaxation, and depressed responses to beta-adrenergic stimulation.
48 ude of contraction) but were unresponsive to beta-adrenergic stimulation.
49 e explained by changes in the sensitivity to beta-adrenergic stimulation.
50 ng the contractile responses of the heart to beta-adrenergic stimulation.
51 culum which is phosphorylated in response to beta-adrenergic stimulation.
52 n cardiac contractile parameters and loss of beta-adrenergic stimulation.
53 creased cardiac contractility in response to beta-adrenergic stimulation.
54 ythmias in structurally normal hearts during beta-adrenergic stimulation.
55  contribute to the net stimulatory effect of beta-adrenergic stimulation.
56  refractory for several minutes from further beta-adrenergic stimulation.
57 Ms restores a positive inotropic response to beta-adrenergic stimulation.
58  role in modulating troponin function during beta-adrenergic stimulation.
59 r cTnI (KC-I) or contractile kinetics during beta-adrenergic stimulation.
60 phorylation by protein kinase A (PKA) during beta-adrenergic stimulation.
61 chronotropic but null inotropic responses to beta-adrenergic stimulation.
62  of cTn by phosphorylation of S23/S24 during beta-adrenergic stimulation.
63 ilin-2 and lethal arrhythmias in response to beta-adrenergic stimulation.
64               These effects were reversed by beta-adrenergic stimulation.
65 ance early phase diastolic relaxation during beta-adrenergic stimulation.
66 omoted early-after-depolarisations following beta-adrenergic stimulation.
67 Ca(2+) release in cardiac myocytes evoked by beta-adrenergic stimulation.
68 n adipocyte differentiation and activated by beta-adrenergic stimulation.
69 use of increased intracellular Ca(2+) during beta-adrenergic stimulation.
70 ncy response and the contractile response to beta-adrenergic stimulation.
71 n of spark-mediated J(leak) increases due to beta-adrenergic stimulation.
72 of arrhythmias in human atrial strips during beta-adrenergic stimulation.
73 x sensitized PKA phosphorylation of KCNQ1 to beta-adrenergic stimulation.
74 amatically delayed their decay after a brief beta-adrenergic stimulation.
75 t WT and mutant Kv11.1 channels responded to beta-adrenergic stimulation.
76 nst pro-arrhythmogenic Ca(2+) release during beta-adrenergic stimulation.
77 duction in channel activation in response to beta-adrenergic stimulation.
78 idation and opposes the metabolic effects of beta-adrenergic stimulation.
79                                       During beta-adrenergic stimulation (100 nM isoproterenol), only
80 rrhythmia-prone EBZ tissue to desensitize to beta-adrenergic stimulation 24 hours after CAL.
81  decrease in spark-to-spark delays seen with beta-adrenergic stimulation; (5) inhibiting either PKA o
82  decrease in spark-to-spark delays seen with beta-adrenergic stimulation; (5) inhibiting either PKA o
83 ically paced myocytes, both with and without beta-adrenergic stimulation (70 nM isoproterenol (isopre
84 monary cAMP and AFC were also observed after beta-adrenergic stimulation, a pathway known to promote
85                    Inhibition of GSK3beta by beta-adrenergic stimulation abrogates GSK3beta-induced n
86 ity and impaired chronotropic response under beta-adrenergic stimulation, accompanied by the appearan
87 ed a significant increase in the response to beta-adrenergic stimulation after LVAD (developed tensio
88 e PTX treatment increases the sensitivity to beta-adrenergic stimulation alone and that this could ac
89                                              beta-adrenergic stimulation also induced a broad program
90 ined in both the absence and the presence of beta-adrenergic stimulation although the beta-agonist ac
91 calcium channels become phosphorylated after beta-adrenergic stimulation, although this does not lead
92 ve inotropic response of the murine heart to beta-adrenergic stimulation, an effect that is highly de
93  association between ion channel response to beta-adrenergic stimulation and clinical response to bet
94 4F-AG-AMT displayed cardiac-like response to beta-adrenergic stimulation and contractile properties.
95  of contraction are increased in response to beta-adrenergic stimulation and high-frequency electrica
96  and amplitude of cardiac contraction during beta-adrenergic stimulation and increased stimulus frequ
97  such modulation enhances rather than blunts beta-adrenergic stimulation and is accompanied by increa
98 ation of L-type Ca2+ currents in response to beta-adrenergic stimulation and local increases in cAMP.
99 his blunts the local contractile response to beta-adrenergic stimulation and may serve to protect aga
100 and this process is dynamically regulated by beta-adrenergic stimulation and phosphorylation of phosp
101 n hypertrophic hearts in response to chronic beta-adrenergic stimulation and PKA activation.
102 n hypertrophic hearts in response to chronic beta-adrenergic stimulation and PKA activation.
103 periments were performed to test the role of beta-adrenergic stimulation and PKA phosphorylation of S
104 iminished hypertrophy in response to chronic beta-adrenergic stimulation and pressure overload.
105 e NO/nitrates is independent and additive to beta-adrenergic stimulation and stimulates CGRP release.
106  interactive effect between oil-exposure and beta-adrenergic stimulation and suggests if animals achi
107 n of cGMP in the heart can potently modulate beta-adrenergic stimulation, and alterations in enzyme l
108                This regulation is coupled to beta-adrenergic stimulation, and dysfunction has been as
109  fractional shortening and responsiveness to beta-adrenergic stimulation, and it limited development
110 ncement of cardiac function that occurs upon beta-adrenergic stimulation, and mutations in MyBP-C cau
111 pment and relaxation as a result of enhanced beta-adrenergic stimulation, and reduced MyBP-C phosphor
112 y cytokine expression through alpha- but not beta-adrenergic stimulation, and suggest that such alpha
113 We show that Jhdm2a expression is induced by beta-adrenergic stimulation, and that Jhdm2a directly re
114  loss of inotropic reserve, uncovered during beta-adrenergic stimulation, and the presence of cardiac
115 e (Ca(2+) wave latency) was prolonged during beta-adrenergic stimulation, and was highly dependent on
116 tion, and apoptosis in response to sustained beta-adrenergic stimulation; and (3) the beneficial effe
117 rdiac function and the inotropic response to beta-adrenergic stimulation are impaired in sepsis.
118  insufficient to regulate respiration during beta-adrenergic stimulation, arguing against intracrine
119 arts exhibit positive inotropic responses to beta-adrenergic stimulation as a consequence of protein
120                                      Chronic beta-adrenergic stimulation, as occurs in patients with
121 lates action potential duration (APD) during beta-adrenergic stimulation at different heart rates are
122 sights into arrhythmogenic mechanisms during beta-adrenergic stimulation besides triggered activity a
123                                   To achieve beta-adrenergic stimulation (beta effect), cells were su
124 uggests responsiveness (increase in rate) to beta-adrenergic stimulation (betaAS), as observed experi
125                                              beta-adrenergic stimulation breaks the delicate Ca(2+) e
126 ontractility and the contractile response to beta-adrenergic stimulation by a NO-cGMP-mediated decrea
127 ed that the activation of glycolysis through beta-adrenergic stimulation by endogenous catecholamines
128 v11.1 and T421M-Kv11.1 channels responded to beta-adrenergic stimulation by increasing I(Kv11.1).
129 herefore conclude that systemic nonselective beta-adrenergic stimulation by ISO at concentrations tha
130                                 Responses to beta-adrenergic stimulation (by isoproterenol) were grea
131 AMP (cAMP) concentrations, a known effect of beta-adrenergic stimulation, by addition of dibutyryl cA
132                                        Under beta-adrenergic stimulation, Ca(2+) transient amplitude,
133                                        Under beta-adrenergic stimulation, [Ca2+]m decay was approxima
134 by a Ca-regulated kinase is necessary before beta-adrenergic stimulation can produce additional phosp
135 on of TSC2 gene activity in combination with beta-adrenergic stimulation can reactivate the cell cycl
136                                       During beta-adrenergic stimulation, cardiac troponin I (cTnI) i
137 Our results demonstrate that, in response to beta-adrenergic stimulation, cardiomyocyte function and
138 vate alpha 1-receptors while maintaining the beta-adrenergic stimulation, cells were superfused with
139        However, with increased heart rate or beta-adrenergic stimulation, cTnIS200D mice had less enh
140 show a blunted cardiac inotropic response to beta-adrenergic stimulation despite normal cardiac contr
141 fter induction of apoptotic pathway by using beta-adrenergic stimulation, displayed a similar pattern
142        On pathological pressure overload and beta-adrenergic stimulation, DKO mice are protected agai
143       In PLM knockout (PLM-KO) mice in which beta-adrenergic stimulation does not activate NKA, [Na](
144  is phosphorylated at Ser16 and Thr17 during beta-adrenergic stimulation (eg, isoproterenol).
145                                We found that beta-adrenergic stimulation elicits exocytosis of large
146                                              beta-adrenergic stimulation enhanced ensemble-averaged c
147                                        Acute beta-adrenergic stimulation enhances cardiac contractili
148                             We conclude that beta-adrenergic stimulation enhances the Frank-Starling
149                             We conclude that beta-adrenergic stimulation enhances the gain of the CIC
150  response to IL-1beta via induction of iNOS; beta-adrenergic stimulation enhances the IL-1beta effect
151                             Cold exposure or beta-adrenergic stimulation favors the active thermogeni
152                                        After beta-adrenergic stimulation, GRK2KO myocytes revealed si
153 ac function under stress; however, sustained beta-adrenergic stimulation has been implicated in patho
154 ein-C (MyBP-C), are phosphorylated following beta-adrenergic stimulation; however, their relative con
155 DAC9 show a hypertrophic response to chronic beta-adrenergic stimulation identical to that of wild-ty
156                        But when coupled with beta-adrenergic stimulation in a whole-cell model, the K
157 tudy was to evaluate the diagnostic value of beta-adrenergic stimulation in ARVC.
158 creased by approximately 12% within 3 min of beta-adrenergic stimulation in beating cardiac myocytes.
159  amplitude of the Ca2+ transient produced by beta-adrenergic stimulation in cardiac muscle is due to
160                                              beta-Adrenergic stimulation in heart leads to increased
161  inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricu
162 ort improved force generation in response to beta-adrenergic stimulation in isolated LV (increase in
163 lation of phospholamban and troponin I after beta-adrenergic stimulation in isolated myocytes.
164 al contraction and the inotropic response to beta-adrenergic stimulation in murine ventricular myocyt
165 tentiates the positive inotropic response to beta-adrenergic stimulation in patients with symptomatic
166 e that activation of the Ca-ATPase following beta-adrenergic stimulation in the heart only occurs abo
167 xtent of contractility and relaxation during beta-adrenergic stimulation in the intact animal remain
168 y was undertaken to test the hypothesis that beta-adrenergic stimulation in the setting of membrane d
169 tein accounted for the ICaL insensitivity to beta-adrenergic stimulation in VEDS cardiomyocytes.
170 rophy and enhanced cardiac responsiveness to beta-adrenergic stimulation in vivo.
171 prevents phosphorylation of serine 1928 upon beta-adrenergic stimulation in vivo.
172 tive amplitude-frequency relationship and in beta-adrenergic stimulation, including decreasing and in
173                                              beta-adrenergic stimulation increases cardiac myosin bin
174                           In cardiac muscle, beta-adrenergic stimulation increases contractile force
175                                              beta-adrenergic stimulation increases I(Ks) and results
176                                The fact that beta-adrenergic stimulation increases myocardial oxygen
177                                              beta-Adrenergic stimulation increases SR content and the
178                                              beta-Adrenergic stimulation increases stroke volume in m
179 s show increased TDR compared with LQT1, and beta-adrenergic stimulation increases TDR in both models
180                   These data show that acute beta-adrenergic stimulation increases the [Ca(2+)](SR) t
181 ll, the results presented here indicate that beta-adrenergic stimulation increases the spark-dependen
182 ted lusitropic response of cardiac muscle to beta-adrenergic stimulation indicate a novel pathogenic
183                                      Chronic beta-adrenergic stimulation induces myocardial, but not
184                                In the heart, beta-adrenergic stimulation induces protein kinase A pho
185                        Our data suggest that beta-adrenergic stimulation induces TdP by increasing tr
186  mouse ventricular myocytes by examining how beta-adrenergic stimulation influenced sequences of Ca(2
187  mouse ventricular myocytes by examining how beta-adrenergic stimulation influenced sequences of Ca2+
188  important role in sinus acceleration during beta-adrenergic stimulation, interacting synergistically
189 e hypothesis that sinus rate acceleration by beta-adrenergic stimulation involves synergistic interac
190                                      Because beta-adrenergic stimulation is a frequent trigger of arr
191               Our study shows that increased beta-adrenergic stimulation is a potentially highly sign
192        Contractile reserve during submaximal beta-adrenergic stimulation is attenuated in patients an
193 e increased incidence of Ca(2+) waves during beta-adrenergic stimulation is due to an alteration in t
194 ggest that the increase in arrhythmias after beta-adrenergic stimulation is independent of enhanced E
195 The increase in Ser-845 phosphorylation upon beta-adrenergic stimulation is much more severely impair
196                                              beta-Adrenergic stimulation is the main trigger for card
197                       An important target of beta-adrenergic stimulation is the sarcolemmal L-type Ca
198 lation in the positive inotropic response to beta-adrenergic stimulation is unclear.
199 s the endogenous theta-rhythm and depends on beta-adrenergic stimulation, is only modestly affected i
200                         Under current clamp, beta-adrenergic stimulation (isoprenaline, 30 nm) increa
201 tivation (caffeine and 4-chloro-m-cresol) or beta-adrenergic stimulation (isoproterenol).
202 s if animals achieve very large increases in beta-adrenergic stimulation it could play a compensatory
203                                              beta-Adrenergic stimulation largely overcame the defect
204 s shown that BVR is increased during intense beta-adrenergic stimulation, leading to SCR.
205 d cardiomyocytes exhibited responsiveness to beta-adrenergic stimulation manifest by an increase in s
206             CaMKII and PKA activities during beta-adrenergic stimulation may synergistically facilita
207 equency response; (4) inotropic responses to beta-adrenergic stimulation mediated via canonical beta1
208 s in myocardial excitability are mediated by beta-adrenergic stimulation of a cAMP-sensitive K(+) cur
209                  These data demonstrate that beta-adrenergic stimulation of a PGC-1alpha/ERRalpha/VEG
210     In summary, the beta-2 receptor mediates beta-adrenergic stimulation of alveolar epithelial sodiu
211                               Interestingly, beta-adrenergic stimulation of both Rap1 and ERKs, but n
212 e RyR/FKBP12.6 association, suggesting minor beta-adrenergic stimulation of Ca2+ release through this
213                                              beta-Adrenergic stimulation of cardiac muscle activates
214 vention of C-terminal cleavage did not alter beta-adrenergic stimulation of CaV1.2 in the heart.
215 nsus PKA phosphorylation sites in alpha1C in beta-adrenergic stimulation of CaV1.2, and show that pho
216 ytic cleavage of alpha1C is not required for beta-adrenergic stimulation of CaV1.2.
217 motif abolishes insulin counterregulation of beta-adrenergic stimulation of cyclic AMP accumulation a
218  of CaV1.2 channels in cardiac myocytes, and beta-adrenergic stimulation of L-type Ca2+ currents in t
219 uation by muscarinic cholinergic agonists of beta-adrenergic stimulation of L-type calcium current an
220 y adults demonstrate reduced, not increased, beta-adrenergic stimulation of metabolic rate because of
221                                  Conversely, beta-adrenergic stimulation of PGC-1alpha(-/-) cells res
222                                              beta-Adrenergic stimulation of SR Ca2+ uptake in cells f
223   Furthermore, the ability of PVN to inhibit beta-adrenergic stimulation of the Ca(2+) current was an
224                                              Beta-adrenergic stimulation of the heart results in an e
225                                       During beta-adrenergic stimulation of the heart, there is a dec
226 We aimed to investigate whether simultaneous beta-adrenergic stimulation offsets this balance in youn
227 ) and quantitatively examined the effects of beta-adrenergic stimulation on channel kinetics.
228 etion (NRG-1+/-) and examined the effects of beta-adrenergic stimulation on contractility in the pres
229 kedly with advancing age, but the effects of beta-adrenergic stimulation on filling, and its major de
230 l systems, we studied the effects of chronic beta-adrenergic stimulation on the myocardial and system
231                                The effect of beta-adrenergic stimulation on the relationship between
232 ovel determinants of the inotropic effect of beta-adrenergic stimulation on the ventricular heart mus
233  Ca2+ channel (LCC) phosphorylation, such as beta-adrenergic stimulation or an increased expression o
234                          Conversely, chronic beta-adrenergic stimulation or expression of an activate
235 tor of increased contractility observed with beta-adrenergic stimulation or increased pacing because
236  greatly enhanced contraction in response to beta-adrenergic stimulation (percent increase in contrac
237                                              beta-adrenergic stimulation plays a critical role in acc
238 -dependent protein kinase II (CaMKII) during beta-adrenergic stimulation prevented the decrease in sp
239 -dependent protein kinase II (CaMKII) during beta-adrenergic stimulation prevented the decrease in sp
240 open probability alone or in the presence of beta-adrenergic stimulation produces diastolic Ca releas
241                                   Short-term beta-adrenergic stimulation promotes contractility in re
242                                              beta-adrenergic stimulation promotes expansion and survi
243                                              beta-Adrenergic stimulation rapidly activated PKA, which
244 S1928 displaces the beta2AR from Cav1.2 upon beta-adrenergic stimulation rendering Cav1.2 refractory
245 n of PKA substrates, elicited in response to beta-adrenergic stimulation, require spatially confined
246                                              Beta-adrenergic stimulation resulted in a blunted rise o
247                                        Thus, beta-adrenergic stimulation results in phosphorylation o
248                           In the presence of beta-adrenergic stimulation, RyR-mediated Ca leak produc
249                           Additionally, with beta-adrenergic stimulation, scavenging of mitochondrial
250                                              beta-Adrenergic stimulation significantly increased Ptra
251                In voltage clamp experiments, beta-adrenergic stimulation still increased SR Ca2+ cont
252 contractions and responding more strongly to beta-adrenergic stimulation than wild-type cells.
253 roteins in the heart to be phosphorylated by beta-adrenergic stimulation, the functional impact of ph
254 on, demonstrating a defect in the ability of beta-adrenergic stimulation to regulate sarcoplasmic ret
255  plus phentolamine (10 micromol/L, selective beta-adrenergic stimulation) to the perfusate.
256 ed sensitivity to frequency potentiation and beta-adrenergic stimulation, two major physiological mec
257 on represents a key signaling mechanism upon beta-adrenergic stimulation under stress.
258            Pharmacological and physiological beta-adrenergic stimulation upregulates FGF10 levels and
259 epolarisations or abnormal automaticity with beta-adrenergic-stimulation, using the dynamic-clamp tec
260      The acute insulin secretory response to beta-adrenergic stimulation was also profoundly suppress
261       Cardiac chronotropic responsiveness to beta-adrenergic stimulation was assessed in vitro using
262 pressure development observed in response to beta-adrenergic stimulation was attenuated in TG(S282A)
263 in aP2-/- mice, the plasma FFA profile after beta-adrenergic stimulation was determined.
264 ibitory G-protein (Galpha(i)) suppression of beta-adrenergic stimulation was greater in DHF and rever
265 ulation of Krebs cycle dehydrogenases during beta-adrenergic stimulation was hampered in Mfn2-KO but
266 ronic AF patients, their response to maximal beta-adrenergic stimulation was not impaired.
267    However, cardiac reserve to work load and beta-adrenergic stimulation was reduced.
268 of LL absorption postnatally, and that while beta-adrenergic stimulation was the sole source of endog
269 tolic pressure and the effects of alpha- and beta-adrenergic stimulation were examined in both models
270 erturbations or intrinsic signaling, such as beta-adrenergic stimulation, which regulate cardiac calc
271 t relevant source of intracellular NO during beta-adrenergic stimulation, while no evidence for a mit
272                    Increased SERCA activity (beta-adrenergic stimulation with 1 muM isoproterenol (is
273                                              beta-Adrenergic stimulation with 1.0 micromol/L isoprote
274    Time-averaged [Ca(2+) ]i was increased by beta-adrenergic stimulation with isoprenaline and increa
275  3, and 6 Hz) in basal conditions and during beta-adrenergic stimulation with isoproterenol (2 nmol/L
276                                              beta-Adrenergic stimulation with isoproterenol (isoprena
277 ences measured under control conditions: (1) beta-adrenergic stimulation with isoproterenol (isoprena
278 ences measured under control conditions: (1) beta-adrenergic stimulation with isoproterenol (isoprena
279 not alter the intracellular Ca2+ response to beta-adrenergic stimulation with isoproterenol but atten
280             We hypothesized that blockade of beta-adrenergic stimulation with propranolol would decre
281 in cardiac functional reserve in response to beta-adrenergic stimulation without significant alterati

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top